Alzheimer’s Studies

With ICRC’s twin rooms and Dr Joel Ross—one of the foremost doctors conducting clinical research on Alzheimer’s Disease in the US today—as Medical Director, ICRC is particularly well-suited to provide clinical trial Sponsors with a unique opportunity to conduct Phase Ib/IIa Alzheimer’s Disease trials in a specialist site that meets the needs of such patients.

The center’s twin rooms allow caregivers to stay overnight with study participants, making it ideal for studies involving patients with Alzheimer’s Disease, where the presence of a loved one provides the participant with a greater peace of mind. This factor alone helps minimize stress on these vulnerable patients, helping to eliminate a potentially confounding variable from clinical studies while optimizing patient care.